EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 234 participants.
Also called NCT05429476
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 234 participants
- Registry
-
NCT05429476
-
- Other papers using this trial's data
- Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT05429476. Randomized; double masking; primary purpose treatment. Start 2022-08-17 (actual); primary completion 2024-08-15 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- EXtending the Time Window for Thrombolysis in Posterior Circulation Stroke Without Early CT Signs
- Condition
- Stroke, Acute Ischemic
- Intervention (Drug)
- Tissue Plasminogen Activator (Alteplase)
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Record details
- Record id
cardio:ct-nct05429476- Content hash
0d73bf27ccac8ec99161abecc469b945e309c49fdd6988ab56bda9fb8862af30